Published date: 31 March 2021
This notice was replaced on 31 March 2021
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 31 March 2021)
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
SW1H 0EU
Value of contract
£21,330,072.60
Procurement reference
CF-0154100D0O000000rwimUAA2
Published date
31 March 2021
Closing date
5 November 2020
Closing time
12am
Contract start date
5 November 2020
Contract end date
30 November 2020
Contract type
Supply contract
Procedure type
Call-off from a framework agreement
A mini-competition or direct purchase from a pre-established framework agreement.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
This contract is call off no.2 from a EU Framework Agreement for the Supply of Remdesivir.
More information
Previous notice about this procurement
- Awarded contract
- Published 31 March 2021
Links
-
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kIzn/USBfBd_kONw3ym997MpjE_Ixs_JGGu5gT_nME2l9GTc
- Specific_Contract_Local_Agreement_UK_No_2_NOVEMBER_FINAL_REDACTED
Award information
Awarded date
5 November 2020
Contract start date
5 November 2020
Contract end date
30 November 2020
Total value of contract
£21,330,072.60
This contract was awarded to 1 supplier.
Gilead Sciences Limited
Address
280 High Holborn WC1V 7EE
Reference
None
About the buyer
Contact name
Simeon Hadebe
Address
39 Victoria Street
London
SW1H 0EU
United Kingdom
Share this notice